Security key
48669G105
KAZIA THERAPEUTICS LTD - American Depositary Shares (KZIA)
CUSIP: 48669G105
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / American Depositary Shares
- Shares outstanding
- 11,425,388
- Total 13F shares
- 391,517
- Share change
- +5,317
- Total reported value
- $89,517
- Price per share
- $0.23
- Number of holders
- 11
- Value change
- -$8,321
- Number of buys
- 6
- Number of sells
- 4
Report period
Q2 2024
Institutions
11
Top holders
10
KZIA full security history
Newer quarter: Q3 2024
Previous quarter: Q1 2024
KAZIA THERAPEUTICS LTD SEC filings
KAZIA THERAPEUTICS LTD company facts
Broader feeds
Reporting periods
Holder history for CUSIP 48669G105
Recent filing periods:
Top shareholders of KZIA - KAZIA THERAPEUTICS LTD - American Depositary Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| MORGAN STANLEY |
13F
|
Company |
1.7%
|
197,850
|
$61,294 | — | 31 Mar 2024 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.56%
|
63,956
|
$20,114 | — | 31 Mar 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.43%
|
48,600
|
$15,056 | — | 31 Mar 2024 | |
| XTX Topco Ltd |
13F
|
Company |
0.16%
|
18,487
|
$5,814 | — | 31 Mar 2024 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.16%
|
18,424
|
$5,708 | — | 31 Mar 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.11%
|
12,170
|
$3,831 | — | 31 Mar 2024 | |
| Ground Swell Capital, LLC |
13F
|
Company |
0.1%
|
11,150
|
$3,507 | — | 31 Mar 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
500
|
$155 | — | 31 Mar 2024 | |
| Allworth Financial LP |
13F
|
Company |
0%
|
87
|
$27 | — | 31 Mar 2024 | |
| AdvisorNet Financial, Inc |
13F
|
Company |
0%
|
5
|
$2 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
3
|
$1 | — | 31 Mar 2024 |
Institutional Holders of KAZIA THERAPEUTICS LTD - American Depositary Shares (KZIA) as of Q2 2024
As of 30 Jun 2024,
KAZIA THERAPEUTICS LTD - American Depositary Shares (KZIA) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
391,517 shares.
The largest 10 holders included
MORGAN STANLEY, BNP PARIBAS FINANCIAL MARKETS, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Virtu Financial LLC, UBS Group AG, RHUMBLINE ADVISERS, CITADEL ADVISORS LLC, WELLS FARGO & COMPANY/MN, Allworth Financial LP, and AdvisorNet Financial, Inc.
This page lists
11
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
11
Q2 2024 holders
11
Holder diff
0
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.